Related Experiment Video
Updated: Jul 30, 2025

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq
Published on: April 19, 2013
Prioritization of genes associated with type 2 diabetes mellitus for functional studies
Wei Xuan Tan1,2, Xueling Sim3, Chin Meng Khoo2
1Stem Cells and Diabetes Laboratory, Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
Abstract:
Existing therapies for type 2 diabetes mellitus (T2DM) show limited efficacy or have adverse effects. Numerous genetic variants associated with T2DM have been identified, but progress in translating these findings into potential drug targets has been limited. Here, we describe the tools and platforms available to identify effector genes from T2DM-associated coding and non-coding variants and prioritize them for functional studies. We discuss QSER1 and SLC12A8 as examples of genes that have been identified as possible T2DM candidate genes using these tools and platforms. We suggest further approaches, including the use of sequencing data with increased sample size and ethnic diversity, single-cell omics data for analyses, glycaemic trait associations to predict gene function and, potentially, human induced pluripotent stem cell 'village' cultures, to strengthen current gene functionalization workflows. Effective prioritization of T2DM-associated genes for experimental validation could expedite our understanding of the genetic mechanisms responsible for T2DM to facilitate the use of precision medicine in its treatment.
Insights
Identifying genes linked to type 2 diabetes mellitus (T2DM) is crucial for new treatments. This study presents tools to find and prioritize T2DM genes, aiming to advance precision medicine for better diabetes management.
Area of Science:
- Genetics
- Metabolic Diseases
- Pharmacogenomics
Background:
- Current type 2 diabetes mellitus (T2DM) treatments have limitations in efficacy and side effects.
- Despite identifying numerous T2DM-associated genetic variants, translating these into viable drug targets remains a challenge.
Purpose of the Study:
- To outline tools and platforms for identifying and prioritizing effector genes from T2DM-associated genetic variants.
- To highlight QSER1 and SLC12A8 as examples of potential T2DM candidate genes identified through these methods.
- To propose enhanced strategies for strengthening gene functionalization workflows in T2DM research.
Main Methods:
- Utilizing bioinformatics tools and platforms to identify effector genes from coding and non-coding T2DM-associated variants.
- Prioritizing candidate genes for subsequent functional studies.
- Reviewing existing and proposing novel approaches for gene discovery and validation.
Main Results:
- Demonstrated the application of specific tools and platforms in identifying candidate T2DM genes, exemplified by QSER1 and SLC12A8.
- Provided a framework for prioritizing genetic variants for functional investigation in T2DM.
Conclusions:
- Effective prioritization of T2DM-associated genes is essential for advancing our understanding of the disease's genetic underpinnings.
- Enhanced gene functionalization workflows, incorporating larger and diverse datasets and advanced omics technologies, can accelerate the development of precision medicine for T2DM.
More Related Videos
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
Published on: August 21, 2016
05:53Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...